Form 4 for ZBH Zimmer Biomet
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-21 · accession 0001062993-23-004629 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-23 | 2023-02-21 | ZBH | Hanson Bryan C | Pres, CEO, Dir | M - OptEx | $0.00 | +15.1K | 107.5K | +16% | $0 |
| D | 2023-02-23 | 2023-02-21 | ZBH | Hanson Bryan C | Pres, CEO, Dir | F - Tax | $124.73 | -4,752 | 102.8K | -4% | -$592.7K |
| D | 2023-02-23 | 2023-02-21 | ZBH | Hanson Bryan C | Pres, CEO, Dir | M - OptEx | $0.00 | -15.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | M | A | 15,132 | $0.00 | 107,549 | D | — | — | (F1) This number of restricted stock units ("RSU's") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. (F2) Includes 194 shares acquired under the Company's Employee Stock Purchase Plan June 30, 2022. |
| 2 | Common | Common Stock | 2023-02-21 | F | D | 4,752 | $124.73 | 102,797 | D | — | — | (F3) Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs. |
| 3 | Derivative | Restricted Stock Units | 2023-02-21 | M | D | 15,132 | $0.00 | 0 | D | — · 2023-02-21 to 2023-02-21 | 15,132 Common Stock | (F1) This number of restricted stock units ("RSU's") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. (F4) Each RSU represents a contingent right to receive one share of Company common stock. |